ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

May 15, 1981

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers

January 24, 1997